Search results for "Rating"

showing 10 items of 2021 documents

Corpus callosum area in patients with bipolar disorder with and without psychotic features: an international multicentre study

2015

Background Previous studies have reported MRI abnormalities of the corpus callosum (CC) in patients with bipolar disorder (BD), although only a few studies have directly compared callosal areas in psychotic versus nonpsychotic patients with this disorder. We sought to compare regional callosal areas in a large international multicentre sample of patients with BD and healthy controls. Methods We analyzed anatomic T-1 MRI data of patients with BD-I and healthy controls recruited from 4 sites (France, Germany, Ireland and the United States). We obtained the mid-sagittal areas of 7 CC subregions using an automatic CC delineation. Differences in regional callosal areas between patients and contr…

AdultMaleoasis brain databasePediatricsmedicine.medical_specialtyBipolar DisorderNeuroimagingshapeLithiumCorpus callosumearly alzheimers-diseasesizeCorpus CallosumGermanyImage Processing Computer-AssistedmedicineHumansPharmacology (medical)In patientBipolar disorderPsychiatryCognitive impairmentmriBiological Psychiatrycognitive impairmentreliabilitymedicine.diagnostic_testExtramuralbusiness.industryMagnetic resonance imagingMiddle Agedmedicine.diseaseMagnetic Resonance ImagingWhite MatterUnited States3. Good healthDiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthMulticenter studyLinear ModelsFemaleabnormalitiesFrancei disorderbusinessrating-scaleIrelandResearch PaperAntipsychotic AgentsJournal of Psychiatry and Neuroscience
researchProduct

Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2–Posit…

2015

Purpose Modulation of immunologic interactions in cancer tissue is a promising therapeutic strategy. To investigate the immunogenicity of human epidermal growth factor receptor 2 (HER2) –positive and triple-negative (TN) breast cancers (BCs), we evaluated tumor-infiltrating lymphocytes (TILs) and immunologically relevant genes in the neoadjuvant GeparSixto trial. Patients and Methods GeparSixto investigated the effect of adding carboplatin (Cb) to an anthracycline-plus-taxane combination (PM) on pathologic complete response (pCR). A total of 580 tumors were evaluated before random assignment for stromal TILs and lymphocyte-predominant BC (LPBC). mRNA expression of immune-activating (CXCL9, …

AdultOncologyCancer Researchmedicine.medical_specialtyStromal cellReceptor ErbB-2medicine.medical_treatmentAntineoplastic AgentsTriple Negative Breast NeoplasmsCarboplatinchemistry.chemical_compoundLymphocytes Tumor-InfiltratingPredictive Value of TestsInternal medicineBiomarkers TumormedicineHumansAgedRandomized Controlled Trials as TopicChemotherapybusiness.industryTumor-infiltrating lymphocytesCancerFOXP3Middle AgedPrognosismedicine.diseaseNeoadjuvant TherapyCarboplatin3. Good healthCD8AGene Expression Regulation NeoplasticOncologychemistryChemotherapy AdjuvantCXCL9FemalebusinessJournal of Clinical Oncology
researchProduct

Autoantibodies in breast cancer: their use as an aid to early diagnosis

2007

There is increasing evidence that the immune system produces a humoral response to cancer-derived antigens. This study assessed the diagnostic potential of autoantibodies to multiple known tumour-associated proteins.Sera from normal controls (n = 94), primary breast cancer patients (n = 97) and patients with ductal carcinoma in situ (DCIS) (n = 40) were investigated for the presence of autoantibodies to p53, c-myc, HER2, NY-ESO-1, BRCA1, BRCA2 and MUC1 antigens by enzyme-linked immunosorbent assay.Reproducibly elevated levels of autoantibodies were seen in at least one of the six antigens in 64% of primary breast cancer patient sera and 45% of patients with DCIS at a specificity of 85%. No …

AdultOncologyPathologymedicine.medical_specialtyAntibodies NeoplasmBreast NeoplasmsEnzyme-Linked Immunosorbent Assaymedicine.disease_causeSensitivity and SpecificityAutoimmunityCohort StudiesBreast cancerAntigenAntigens NeoplasmInternal medicinemedicineHumansMammographyNeoplasm Metastasisskin and connective tissue diseasesLymph nodeAgedAutoantibodiesAged 80 and overmedicine.diagnostic_testbusiness.industryAutoantibodyReproducibility of ResultsCancerHematologyMiddle Agedmedicine.diseaseCarcinoma LobularCarcinoma Intraductal NoninfiltratingEarly Diagnosismedicine.anatomical_structureIncreased riskReceptors EstrogenOncologyCase-Control StudiesFemalebusinessAnnals of Oncology
researchProduct

Monocyte Chemoattractant Protein-1 Serum Levels in Patients with Breast Cancer

2003

The chemokine monocyte chemoattractant protein (MCP)-1 is thought to be involved in breast carcinogenesis. We evaluated MCP-1 serum levels in patients with breast cancer (n = 135), ductal carcinoma in situ (DCIS) I-III (n = 30), benign breast lesions (n = 143) and in healthy women (n = 27). We determined the value of MCP-1 serum levels as a differentiation marker between malignant, preinvasive and benign breast diseases and as a predictive marker for the biological phenotype of breast carcinoma. Median (range) MCP-1 serum levels in patients with breast cancer, DCIS I-III, benign breast lesions and healthy women were 200 (57-692) pg/ml, 194 (58-525) pg/ml, 174 (39-529) pg/ml and 175 (67-425)…

AdultOncologymedicine.medical_specialtyCA 15-3Breast NeoplasmsBreast DiseasesBreast cancerReference ValuesInternal medicineBiomarkers TumormedicineCarcinomaHumansNeoplasm Invasivenessskin and connective tissue diseasesLymph nodeChemokine CCL2AgedRetrospective StudiesPredictive markerbusiness.industryCase-control studyGeneral MedicineMiddle AgedDuctal carcinomamedicine.diseaseCarcinoma Intraductal NoninfiltratingCell Transformation NeoplasticPhenotypemedicine.anatomical_structureCase-Control StudiesLymphatic MetastasisFemaleBreast carcinomabusinessTumor Biology
researchProduct

Imunohistochemical Demonstration of Carcinoembryonic Antigen (CEA) in 120 Mammary Carcinomas and its Correlation with Tumor Type, Grading, Staging Pl…

1985

Antisera to CEA were used for the immunohistochemical localization and quantification of this antigen in 120 Bouin-fixed, paraffin embedded mammary carcinomas. These results were compared to tumor type, grading, staging, biochemical receptor status, cytosolic CEA-levels of the same tumors, and preoperative plasma CEA-levels. Mammary carcinomas were usually characterized by a low percentage of CEA-positive tumor cells: 50.9% of the cases contained more than 5% CEA-positive tumor cells and were therefore defined as being CEA-histopositive in this study. A relation could be shown between CEA-histopositivity and the histologic tumor type. The majority of invasive lobular carcinomas, tubular, an…

AdultPathologymedicine.medical_specialtyReceptor Statusendocrine system diseasesBreast NeoplasmsPathology and Forensic MedicineImmunoenzyme TechniquesCarcinoembryonic antigenAntigenAntigens NeoplasmmedicineCarcinomaHumansneoplasmsEstrogen Receptor StatusGrading (tumors)Agedbiologybusiness.industryCarcinomaCell BiologyMiddle Agedmedicine.diseasedigestive system diseasesCarcinoembryonic AntigenCarcinoma Intraductal NoninfiltratingReceptors EstrogenInvasive lobular carcinomabiology.proteinImmunohistochemistryFemalebusinessPathology - Research and Practice
researchProduct

On the complementarity of holistic and analytic approaches to performance assessment scoring.

2019

BACKGROUND A holistic approach to performance assessment recognizes the theoretical complexity of multifaceted critical thinking (CT), a key objective of higher education. However, issues related to reliability, interpretation, and use arise with this approach. AIMS AND METHOD Therefore, we take an analytic approach to scoring students' written responses on a performance assessment. We focus on the complementarity of holistic and analytic approaches and on whether theoretically developed analytical scoring rubrics can produce sub-scores that may measure the 'whole' performance in a holistic assessment. SAMPLE We use data from the Wind Turbines performance assessment, developed in the iPAL p…

AdultPerformance based assessmentEducational measurementHigher educationUniversitiesMachine learningcomputer.software_genreEducationThinkingYoung AdultAcademic PerformanceDevelopmental and Educational PsychologyHumans0501 psychology and cognitive sciencesTest interpretationStudentsRating schemebusiness.industry05 social sciences050301 educationRubricComplementarity (physics)Critical thinkingArtificial intelligenceEducational MeasurementbusinessPsychology0503 educationcomputer050104 developmental & child psychologyThe British journal of educational psychologyReferences
researchProduct

Consistencies and discrepancies in self- and observer-rated anxiety scales. A comparison between the self- and observer-rated Marks-Sheehan scales.

1990

The Marks-Sheehan anxiety scales are the only scales where self-ratings and observer ratings are perfectly matched by the number, the content and the scaling of the items. Therefore these scales are an excellent tool to investigate the compatibility and to study different structures in self- and observer ratings. This was done by using the data material on the Marks-Sheehan scales of the Cross National Collaborative Panic Study. In this study 1168 outpatients who met the DSM-III criteria for panic disorder were randomly allocated either to alprazolam, imipramine or placebo treatment. Our results show that the Marks-Sheehan scales are highly comparable to other established rating scales. Bot…

AdultPersonality TestsImipraminePersonality Assessmentbehavioral disciplines and activitiesDouble-Blind MethodRating scalemedicineHumansPharmacology (medical)Biological PsychiatryAlprazolamGeneral NeurosciencePanic disorderSelfBehaviorally anchored rating scalesPanicGeneral MedicineMiddle Agedmedicine.diseaseAnxiety DisordersPanicObserver ratingPsychiatry and Mental healthNeuropsychology and Physiological PsychologyAlprazolamAnxietymedicine.symptomPsychologySocial psychologymedicine.drugClinical psychologyEuropean archives of psychiatry and clinical neuroscience
researchProduct

Self- and observer assessment in anxiolytic drug trials: A comparison of their validity

1990

Self-rating scales are considered to be less useful for comparing different treatments in anxiety patients than observer-rating scales. However, the empirical evidence for this assumption is not adequate. A self-rating inventory of 35 items related to anxiety was perfectly parallel with an observer-rating inventory. Both instruments were used in the Cross National Collaborative Panic Study to compare the efficacy of imipramine, alprazolam and placebo in an 8-week drug trial in a sample of 1168 outpatients. The variance of the self-rating assessments was about two times higher. Both scales were equally sensitive to change; however, the measurement of change by means of the self-rating scale …

AdultPersonality TestsImipraminemedicine.medical_specialtyPsychometricsPsychometricsmedicine.drug_classPersonality AssessmentAnxiolyticDouble-Blind MethodRating scalemedicineHumansPharmacology (medical)PsychiatryBiological PsychiatryAlprazolamGeneral NeurosciencePanic disorderReproducibility of ResultsPanicGeneral MedicineMiddle Agedmedicine.diseaseAnxiety DisordersPanicPsychiatry and Mental healthNeuropsychology and Physiological PsychologyAlprazolamAnxietymedicine.symptomPersonality Assessment InventoryPsychologyClinical psychologymedicine.drugEuropean Archives of Psychiatry and Clinical Neuroscience
researchProduct

Prediction of Course in Major Depression. Does Psychopathology Predict Future Drug Intake or Relapse?

1988

AdultPsychiatric Status Rating ScalesDepressive Disordermedicine.medical_specialtybusiness.industryGeneral MedicineMiddle AgedPrognosisPsychiatry and Mental healthRecurrencemedicineHumansPharmacology (medical)Drug intoxicationPsychiatrybusinessDepression (differential diagnoses)Clinical psychologyPsychopathologyPharmacopsychiatry
researchProduct

Context, remember–know recognition judgements, and ROC parameters

2007

Recent work (e.g., Dunn, 2004; Heathcote, 2003) has questioned the necessity of postulating two processes to explain recognition memory. As part of this trend, strength theories of the remember-know methodology have gained in support. We present three experiments with pictorial material in which we force participants to use differential contextual information at test. Participants were required to give remember-know judgements and confidence ratings for each test stimulus. Hits, false alarms, remember-know data, and discrimination indices indicated systematic variations as a function of the availability and use of contextual information. Moreover, when we normalised the receiver operating c…

AdultPsychological TestsReceiver operating characteristicRecallRecognition PsychologyContext (language use)Test stimulusTest (assessment)JudgmentROC CurveArts and Humanities (miscellaneous)Mental RecallHumansContextual informationSet (psychology)PsychologySocial psychologyGeneral PsychologyRecognition memoryCognitive psychologyMemory
researchProduct